These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27607327)

  • 1. Medical management of vascular anomalies.
    Trenor CC
    Semin Cutan Med Surg; 2016 Sep; 35(3):177-81. PubMed ID: 27607327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus for the treatment of children with various complicated vascular anomalies.
    Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
    Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical management of vascular anomalies.
    Blei F
    Facial Plast Surg; 2012 Dec; 28(6):575-83. PubMed ID: 23188684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical and sclerosing agents in the treatment of orbital lymphatic malformations: what's new?
    Lam SC; Yuen HKL
    Curr Opin Ophthalmol; 2019 Sep; 30(5):380-385. PubMed ID: 31232717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus for the treatment of complicated vascular anomalies in children.
    Hammill AM; Wentzel M; Gupta A; Nelson S; Lucky A; Elluru R; Dasgupta R; Azizkhan RG; Adams DM
    Pediatr Blood Cancer; 2011 Dec; 57(6):1018-24. PubMed ID: 21445948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of vascular anomalies of the head and neck.
    Léauté-Labrèze C
    J Oral Pathol Med; 2022 Nov; 51(10):837-843. PubMed ID: 35668029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign aggressive vascular anomalies in children].
    Boccara O; Maruani A; Léauté-Labrèze C
    Bull Cancer; 2018 Jun; 105(6):610-625. PubMed ID: 29571951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
    Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
    Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants.
    Czechowicz JA; Long-Boyle JR; Rosbe KW; Mathes EF; Frieden IJ; Shimano KA
    Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():48-51. PubMed ID: 29447818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How we approach the use of sirolimus and new agents: Medical therapy to treat vascular anomalies.
    Shimano KA; Eng W; Adams DM
    Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e29603. PubMed ID: 35253343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
    Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone.
    Kim D; Benjamin L; Wysong A; Hovsepian D; Teng J
    Dermatol Ther; 2015; 28(4):218-21. PubMed ID: 25753853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
    Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
    Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new treatment for vascular anomalies: Six cases treated with rapamycin].
    Thirion S; Jamblin P; Demarche M; Boon L; Thiry A; Hoyoux C
    Arch Pediatr; 2017 Jul; 24(7):600-606. PubMed ID: 28595829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-Based Management of Vascular Malformations.
    Morgan P; Keller R; Patel K
    Facial Plast Surg; 2016 Apr; 32(2):162-76. PubMed ID: 27097138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
    Freixo C; Ferreira V; Martins J; Almeida R; Caldeira D; Rosa M; Costa J; Ferreira J
    J Vasc Surg; 2020 Jan; 71(1):318-327. PubMed ID: 31676179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-center experience with sirolimus therapy for vascular malformations.
    Yesil S; Tanyildiz HG; Bozkurt C; Cakmakci E; Sahin G
    Pediatr Hematol Oncol; 2016 Apr; 33(3):219-25. PubMed ID: 27128161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.
    Badia P; Ricci K; Gurria JP; Dasgupta R; Patel M; Hammill A
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28088. PubMed ID: 31930696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex vascular anomalies.
    Azizkhan RG
    Pediatr Surg Int; 2013 Oct; 29(10):1023-38. PubMed ID: 23989523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.
    Adams DM; Trenor CC; Hammill AM; Vinks AA; Patel MN; Chaudry G; Wentzel MS; Mobberley-Schuman PS; Campbell LM; Brookbank C; Gupta A; Chute C; Eile J; McKenna J; Merrow AC; Fei L; Hornung L; Seid M; Dasgupta AR; Dickie BH; Elluru RG; Lucky AW; Weiss B; Azizkhan RG
    Pediatrics; 2016 Feb; 137(2):e20153257. PubMed ID: 26783326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.